Company: SXTPW
Filing Date: 2025-02-06
Form Type: 424B5
Source: 0001213900-25-010772
Chunk: 38

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-02-06
Form: 424B5
Chunk 38
---
 | 2,898,551                                                                                     
 shares of common stock issuable upon exercise of outstanding Series B warrants at an exercise 
 price of $1.38 per share;                                                                     |

| ● | 7,076                                                                                                                                    
 shares of common stock issuable upon exercise of the representative warrants issued to the representative in our initial public offering 
 in July 2023 at an exercise price of $5.082 per share;                                                                                   |

| ● | 31,300                                                                                                                               
 shares of common stock issuable upon exercise of the representative warrants to the representative in our public offering in January 
 2024 at an exercise price of $69.96 per share;                                                                                       |

| ● | 217,391                                                                                                                          
 shares of common stock issuable upon exercise of the warrants issued to the placement agent in our private placement offering in 
 September 2024 at an exercise price of $1.725 per share;                                                                         |

| ● | shares                                                                                     
 of common stock issuable upon the conversion of 76,480 shares of Series A Preferred Stock; |

| ● | 1,666,670 shares of common stock issuable upon                                                                               
 the exercise of the private placement warrants issued in the January 2025 Offering at an exercise price of $0.771 per share; |

| ● | 1,503,500                                                                                                                            
 shares of common stock issuable upon the exercise of the Private Placement Warrants to issued in the concurrent private placement at 
 an exercise price of $0.59 per share;                                                                                                |

| ● | 76,616 shares of common stock issuable upon the exercise of placement agent warrants issued as compensation to the placement agent (or its designee) in connection with the January 2025 Offering at an exercise price of $1.2763 per share; and |

| ● | 112,763 shares of common stock issuable upon the                                                                                            
 exercise of placement agent warrants to be issued as compensation to the placement agent (or its designee) in connection with this offering 
 at an exercise price of $0.8938 per share.                                                                                                  |

<div align='center'>S-22

DESCRIPTION OF SECURITIES</div>

Description of the Common Stock

A description of the common stock we are offering
pursuant to this prospectus supplement is set forth under the heading “Description of Capital Stock – Common Stock,”
starting on page 21 of the accompanying prospectus. As of February 5, 2025, we had 5,861,